French biotech Overseed raises €6.7 million to become local manufacturer of 100% medical cannabis medicines
Within a strict pharmaceutical framework, France is preparing to authorize the use and health insurance coverage of medical cannabis in January 2025. In this context, Orléans-based Overseed Biotech, which specializes in agronomic research and the development of medicines derived from the cannabis plant, has announced a €6.7 million Series A fundraising, following a €2.5 million seed […]